A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/16/1997	WO1997037998A2 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997	WO1997037966A1 Quaternary cytofectins
10/16/1997	WO1997037691A1 Telomerase inhibitors
10/16/1997	WO1997037690A2 Cytomodulating conjugates of members of specific binding pairs
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	WO1997037680A1 Macromolecular complexes for drug delivery
10/16/1997	WO1997037679A1 Interferon-gamma anti-inflammatory methods, compounds, and pharmaceutical compositions
10/16/1997	WO1997037678A1 Drug for the treatment of tumours
10/16/1997	WO1997037677A1 A synthetic peptide and its uses
10/16/1997	WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	WO1997037675A1 Prolonging survival of transplanted pancreatic cells
10/16/1997	WO1997037674A1 Substance originating in germinating seeds of gramineous plant and containing proteins and insoluble dietary fibers and use thereof
10/16/1997	WO1997037669A1 Oligonucleotides with anti-epstein-barr virus activity
10/16/1997	WO1997037668A1 Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation
10/16/1997	WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	WO1997037654A1 Use of photopheresis in the treatment of chronic infection by hepatitis c virus
10/16/1997	WO1997037643A1 Process and product for the treatment of arthritis
10/16/1997	WO1997037636A1 Therapeutic and preventive method against harmful microbes
10/16/1997	WO1997037542A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997	WO1997033551A3 Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
10/16/1997	WO1997030975A3 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
10/16/1997	WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997	WO1997028826A3 Contraceptive release systems with antibacterial and/or antiviral effect
10/16/1997	WO1997026276A3 Vertebrate fringe proteins
10/16/1997	WO1997025071A3 Immunoconjugate for the treatment of aids
10/16/1997	WO1997024138A3 Medical use of proteases
10/16/1997	WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997	DE19614099A1 Genomische Nukleinsäuren, die für Polypeptide mit IL-16-Aktivität codieren, Verfahren zu ihrer Herstellung und Verwendung Genomic nucleic acids, which encode polypeptides with IL-16 activity, processes for their preparation and use
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0\|heptan-7-one derivatives as cysteine protease inhibitors
10/16/1997	CA2251603A1 Gene family associated with neurosensory defects
10/16/1997	CA2251595A1 Prolonging survival of transplanted pancreatic cells
10/16/1997	CA2251593A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto
10/16/1997	CA2251578A1 Novel signal transducer
10/16/1997	CA2251569A1 Genomic nucleic acids, cdna and mrna which code for polypeptides with il-16 activity, processes for the production thereof and their use
10/16/1997	CA2251464A1 Non-dendritic backbone peptide carrier
10/16/1997	CA2251264A1 Human hyaluronan receptor
10/16/1997	CA2251078A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997	CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	CA2250868A1 Human cachexia associated protein
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997	CA2250839A1 Drug for the treatment of tumours
10/16/1997	CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	CA2250722A1 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997	CA2250268A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997	CA2249430A1 The substance containing proteins and insoluble dietary fibers derived from the germinated seed of a grass family plant and uses thereof
10/16/1997	CA2249213A1 Extracellular/epidermal growth factor-like protein
10/16/1997	CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/15/1997	EP0801132A2 Staphylococcal FtsH protein
10/15/1997	EP0801076A1 Thrombocytotic factor
10/15/1997	EP0801075A1 Covalently linked dimers of glycopeptide antibiotics
10/15/1997	EP0801074A1 Isolation of peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
10/15/1997	EP0800829A1 Antitumor agent potentiator comprising il-6 antagonist
10/15/1997	EP0800828A1 Transmucosal preparation
10/15/1997	EP0800649A1 Inhibition of glial cell proliferation
10/15/1997	EP0800585A1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
10/15/1997	EP0800581A1 POLYMERASE $g(d) MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS
10/15/1997	EP0800580A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases
10/15/1997	EP0800579A2 Combination gene delivery vehicles
10/15/1997	EP0800578A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
10/15/1997	EP0800536A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
10/15/1997	EP0800535A1 Fibronectin adhesion inhibitors
10/15/1997	EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997	EP0800533A1 Anti-inflammatory cd14 peptides
10/15/1997	EP0800532A1 Improved cyclic crf agonists
10/15/1997	EP0800531A2 Novel receptor tyrosine kinases
10/15/1997	EP0800530A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
10/15/1997	EP0800528A1 Peptide and peptide analog protease inhibitors
10/15/1997	EP0800527A1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
10/15/1997	EP0800405A1 Continuous low-dose administration of parathyroid hormone or its agonist
10/15/1997	EP0800403A2 Non-traumatic administration of gene delivery vehicles
10/15/1997	EP0800402A1 Mobilisation of haematopoietic cells
10/15/1997	EP0800399A1 Combined therapeutical treatment of hyperproliferative diseases
10/15/1997	EP0800398A1 CLEAVAGE OF 5$g(a)-REDUCTASE MRNA
10/15/1997	EP0800394A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals
10/15/1997	EP0772396A4 Method of regulating immune function
10/15/1997	EP0646013A4 Platelet derived growth factor antagonists.
10/15/1997	EP0460178B1 Cd4 specific recombinant antibody
10/15/1997	EP0294469B1 Vaccines and diagnostic assays for haemophilus influenzae
10/15/1997	EP0179075B2 Virus risk-reduced hemoglobin and method for making same
10/15/1997	CN1162335A Modified human C3 proteins
10/15/1997	CN1162318A New peptide active substance and production thereof
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/15/1997	CN1162266A Novel brain endothelial cell protein and methods for its use
10/15/1997	CN1162265A Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability and process for producing them
10/15/1997	CN1161861A Novel use of gluten peptides as stimulator of mineral absorption and preventive agent of diseases
10/14/1997	US5677448 Sulfonamidocarboxamides
10/14/1997	US5677430 Hodgkin*s disease
10/14/1997	US5677429 Vaccine
10/14/1997	US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase
10/14/1997	US5677426 Anti-IL-8 antibody fragments
10/14/1997	US5677421 Target proteins for eukaryotic tyrosine kinases
10/14/1997	US5677420 Phospholipase c-inhibiting peptides
10/14/1997	US5677419 Cyclic vasoactive peptide analogs
10/14/1997	US5677337 Adminstering as anticarcinogenic agents
10/14/1997	US5677297 Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/14/1997	US5677285 Derivatives of neuraminic acid
10/14/1997	US5677284 Charged collagen particle-based delivery matrix

1 ... 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 ... 3163